Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule Gastroscopy

Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule Gastroscopy

The aim of our study was to demonstrate the efficacy and feasibility of the medical consortium for screening upper gastrointestinal cancers with magnetically controlled capsule gastroscopy.

In this study, the investigators designed a propective cohort study to evaluate the the efficacy and feasibility of medical consortium for screening upper gastrointestinal cancers (MCSC) with magnetically controlled capsule gastroscopy (MCCG).

Inclusion Criteria:

• asymptomatic subjects undergong magnetically controlled capsule gastroscopy for health checkup in medical consotium;
• subjects able to give informed consent

Exclusion Criteria:

• suspected or known intestinal stenosis, obstruction, or fistula;
• inoperability of refusal to accept any abdominal surgery;
• dysphagia or gastric paralysis;
• previous history of gastrointestinal disease;
• with pacemaker, implanted-cardiac defibrillator or other implanted electromedical devices;
• need for standard magnetic resonance imaging examination within seven days after swallowing the MCCG, unless the capsule is confirmed to have been excreted;
• other factors that are not suitable for inclusion evaluated by medical stuff